z-logo
Premium
Influence of Prostaglandin I 2 on Fibronectin‐Mediated Phagocytosis In Vivo and In Vitro
Author(s) -
Weinberg David A.,
Weston Lisa K.,
Kaplan John E.
Publication year - 1985
Publication title -
journal of leukocyte biology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.819
H-Index - 191
eISSN - 1938-3673
pISSN - 0741-5400
DOI - 10.1002/jlb.37.2.151
Subject(s) - phagocytosis , biology , in vitro , in vivo , fibronectin , prostaglandin , prostaglandin e2 , microbiology and biotechnology , immunology , biochemistry , endocrinology , extracellular matrix
This study evaluated the effect of prostaglandin I 2 (PGI 2 )on fibronectin‐me‐ diated macrophage phagocytosis in vivo and in vitro. Phagocytosis measured in vivo in rats by the vascular clearance rate and hepatic localization of gelatinized sheep erythrocytes was inhibited in a dose‐dependent manner after intravenous administration of PGI 2 . Phagocytosis was assessed in vitro in terms of uptake of fibronectin‐dependent gelatinized sheep erythrocytes by monolayers of casein‐elicited rat peritoneal macrophages. Concentrations of 1 ng/ml PGI 2 or greater resulted in inhibition of particle internalization but not attachment to macrophages. This inhibitory effect was enhanced by amino‐ phylline, a phosphodiesterase inhibitor. PGI 2 increased cAMP levels and these were further increased in the presence of aminophylline. These data indicate that PGI 2 inhibits macrophage uptake of gelatinized particles and support the idea that this is mediated by increased intracellular levels of cyclic AMP. PGI 2 should thus be considered a potential etiologic factor in the phagocytic depression observed in association with thrombosis.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom